Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)

Documenti analoghi

• A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
  di: Ólafsdóttir, Arndís F., et al.
  Pubblicazione: (2018)
• The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)
  di: Ólafsdóttir, Arndís F., et al.
  Pubblicazione: (2020)
• The Association Between HbA(1c) and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
  di: Seyed Ahmadi, Shilan, et al.
  Pubblicazione: (2020)
• Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
  di: Lind, Marcus, et al.
  Pubblicazione: (2015)
• Flash Continuous Glucose Monitoring: Implications for Use of Continuous Data in Daily Diabetes Management
  di: Hirsch, Irl B., et al.
  Pubblicazione: (2019)